Taking innovative research from concept to application is critical for improving health care systems and the well-being of patients. VCHRI is proud to support investigators and their groundbreaking health research with the Innovation and Translational Research Awards. This year’s recipients are using new techniques and emerging technologies to advance patient outcomes and enhance patient-practitioner connectedness in the era of COVID-19.
The 2023 Innovation and Translational Research Award recipients are:
From William Shakespeare to Samuel Beckett, the theatre has often been a space to explore and question cultural identities and beliefs. In her study, Vancouver Coastal Health Research Institute researcher Dr. Tal Jarus assessed how a research-based theatrical performance about health care practitioners living with a disability impacted audience members’ perceptions.
Research-based theatre draws from both theatre and research to create social change.
A novel technique used to treat depression has shown promise as a means of helping relieve some of the symptoms of Parkinson’s disease, according to the preliminary findings of the ongoing Magnetic Seizure Therapy (MST) for Parkinson’s Disease clinical trial.
Oral cancer — also called mouth cancer — affects about 5,400 Canadians every year. Although oral cancer can be treated successfully when caught in its early stages, it generally has a high mortality rate due to late detection. Vancouver Coastal Health Research Institute clinician-scientist Dr. Catherine Poh answers questions about the risk factors for oral cancer and explains how current research is addressing oral cancer awareness across B.C.
A wireless monitoring technique developed by Vancouver Coastal Health Research Institute researcher Dr. Babak Shadgan can help clinicians monitor vital signs and patient health following respiratory diseases, such as pneumonia and COVID-19.
“Our technique can provide measures to help clinicians monitor how well a patient's respiratory system is functioning,” says Shadgan.
Johanna Trimble became an advocate for adverse drug event (ADE) awareness after having more than one family member affected by a problem medication.
ADEs occur when a person experiences harmful side effects from a prescribed medication. Trimble’s sister-in-law, Marilyn, passed away after a medication that had previously harmed her was accidentally re-prescribed by her general practitioner, who was unaware of Marilyn’s previous adverse reaction to the medication.
